SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-19-062715
Filing Date
2019-11-12
Accepted
2019-11-12 17:10:40
Documents
77
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a19-17592_110q.htm 10-Q 1174395
2 EX-4.1 a19-17592_1ex4d1.htm EX-4.1 19027
3 EX-31.1 a19-17592_1ex31d1.htm EX-31.1 10210
4 EX-31.2 a19-17592_1ex31d2.htm EX-31.2 10153
5 EX-32.1 a19-17592_1ex32d1.htm EX-32.1 5551
6 EX-32.2 a19-17592_1ex32d2.htm EX-32.2 5902
13 GRAPHIC g175921kii001.jpg GRAPHIC 5466
  Complete submission text file 0001104659-19-062715.txt   7106972

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT ontx-20190930.xml EX-101.INS 1654924
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ontx-20190930.xsd EX-101.SCH 64681
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ontx-20190930_cal.xml EX-101.CAL 39218
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ontx-20190930_def.xml EX-101.DEF 239279
11 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT ontx-20190930_lab.xml EX-101.LAB 512504
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ontx-20190930_pre.xml EX-101.PRE 410071
Mailing Address 375 PHEASANT RUN NEWTOWN PA 18940
Business Address 375 PHEASANT RUN NEWTOWN PA 18940 267-759-3681
Onconova Therapeutics, Inc. (Filer) CIK: 0001130598 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36020 | Film No.: 191210726
SIC: 2834 Pharmaceutical Preparations